Cardiovascular Risk Categories and Attaining LDL-C Targets in Middle Eastern Adults Aged 30-55 Years of Age

NCT05745272 | Terminated

• 1 other identifier: CVA-G/JCS-1/2023
• Study Type: observational
• Target: 1,000
• Locations: 1 country
• Sites: 1

Brief Summary

Individuals evaluated for primary and secondary cardiovascular prevention have different levels of cardiovascular risk These levels of risk are the main determinants of the low-density lipoprotein cholesterol (LDL-C) target blood levels that need to be attained.

Conditions

Atherosclerotic Cardiovascular Risk; Low-density-lipoprotein (LDL) Cholesterol

Keywords

Low-density lipoprotein cholesterol (LDL-C); LDL-C targets; ASCVD risk levels; Middle East population

Outcome Measures

Primary Outcomes (1)

• Risk level of ASCVD

  Categorizing the patients' level of ASCVD risk by the clinical background of CVD, DM, other risk factors and 10% year risk

  12 MONTHS

Secondary Outcomes (1)

• LDL-cholesterol blood level

  12 months

Eligibility Criteria

• Age: 18 Years - 55 Years
• Sex: all
• Age Groups: Adult (18-64)
• Sampling Method: Non-Probability Sample

Study Population

Ambulatory care patients and in-hospital patients with any medical illness of coming for routine check ups.Age 18-55 both sexes.

You may qualify if:

• Age 18-55 y
• Individuals can give a history of the presence or absence of ASCVD and its risk factors

You may not qualify if:

• Age below 18 or older than 55
• Refusal of inability to give history on ASCVD and its risk factors

Sponsors & Collaborators

• Jordan Collaborating Cardiology Group: lead
• The Cardiovascular Academy Group of the JCS: collaborator
• The Jordan Cardiac Society (JCS): collaborator
• Istishari Hospital Department of Clinical Research: collaborator

Study Sites (1)

Istishari Hospital

Amman, 11184, Jordan

Location

Study Officials

• Imad A. Alhaddad, MD FACC

  Department of Cardiology, Jordan Hospital, Amman, Jordan

  STUDY CHAIR

• Ramzi Tabbalat

  Cardiology Department, Abdali Hospital

  STUDY DIRECTOR

• Ayman Hammoudeh, MD FACC

  Department of Clinical Research, Istishari Hospital, Aman, Jordan

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: February 16, 2023
• First Posted: February 27, 2023
• Study Start: December 11, 2023
• Primary Completion: December 15, 2023
• Study Completion: December 24, 2023
• Last Updated: January 31, 2024

Record last verified: 2024-01

Data Sharing

• IPD Sharing: Will share
• Shared Documents: CSR
• Time Frame: April 2023 for 14 months

Locations

JO (1)